drugset / Trial / NCT06968936

Summary

This is a sub-study of the Preoperative Combined Iron Therapy trail in which some participants will be additionally randomized to combined iron supplementation or standarded treatment control to evaluate the impact on long-term outcomes.

Timeline

Start
2026-03-27
Primary completion
2029-06-30
Completion
2029-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Sucrose Iron Unknown 200 mg Intravenous
Subject Vitamin C Other / unclassified 2 g Intravenous
Subject epoetin alfa Protein / enzyme biologic 150 iu/kg Subcutaneous